Hepatitis C virus infection triggers a tumor-like glutamine metabolism Pierre L. Lévy1, Sarah Duponchel1,2, Hannah Eischeid3, Jennifer Molle1, Maud Michelet1, Gaëlle Diserens4, Martina Vermathen5, Peter Vermathen4, Jean-Francois Dufour4, Hans-Peter Dienes3,6, Hans-Michael Steffen3, Margarete Odenthal3, Fabien Zoulim 1,2, Birke Bartosch1 1Cancer Research Center Lyon, INSERM U1052 and CNRS 5286, Lyon University, 69003 Lyon, France 2 Hospices Civils de Lyon, France 3Institute of Pathology, University of Cologne, Germany 4Dept. of Clinical Research, University of Bern, Bern, Switzerland 5Dept. of Chemistry and Biochemistry, University of Bern, Bern, Switzerland 6Clinical Institute of Pathology, Medical University of Vienna, Austria Keywords: chronic hepatitis C, glutaminolysis, fibrosis, hepatocarcinogenesis This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/hep.28949 This article is protected by copyright. All rights reserved. Hepatology Page 2 of 32 2 Contact information: Birke Bartosch, Cancer Research Center Lyon, 151 cours Albert Thomas, 69434 Lyon, France;
[email protected], Tel 0033472681975, Fax 0033472681971 List of abbreviations: Hepatitis C virus (HCV), hepatocellular carcinoma (HCC), direct antiviral agents (DAA), sustained virological response (SVR), insulin resistance (IR), adenosine triphosphate